We are incredibly proud to announce that our lab’s latest research has not only resulted in crucial developmental and therapeutic insights for the treatment of Hirschsprung disease, but has also been featured on the cover of Development! 🔬
In our newest publication, the research team investigated the migration of enteric neural crest-derived cells (ENCDCs) following transplantation. While stem cell therapy holds great promise for treating enteric neuropathies such as Hirschsprung disease – a condition characterized by the lack of innervation in the colon – the limited spread of transplanted cells has remained a major issue.
Our study reveals that inhibitory molecules in the extracellular matrix (ECM), specifically chondroitin sulfate proteoglycans (CSPGs), strongly restrict ENCDC migration. We demonstrated that modulating the ECM by inhibiting these molecules significantly improves cell migration and integration into the hindgut. This highlights a highly promising new strategy to enhance the success and efficiency of stem cell-based therapies for Hirschsprung disease.
The cover image perfectly illustrates how ECM composition regulates cell migration, with HNK1-positive enteric neural crest-derived cells migrating efficiently on fibronectin-coated stripes, while their movement is blocked by alternating CSPG-coated stripes.
Congratulations to the entire research team on this fantastic scientific achievement and the beautiful cover! 👏
Please find the scientific publication here.